Urothelial Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-09-10
Clinical Trial Update: A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating pembrolizumab plus enfortumab vedotin, with or without investigational age…